Editorial Policy

Last updated: April 27, 2026

Pillo publishes content to help people manage medications more confidently. Most of our readers arrive after searching for something specific — what happens if they missed a dose, whether a vitamin interacts with their prescription, what time of day to take a new pill. Those questions sit at the intersection of practical health information and personal safety, and we treat them that way.

This page explains how we plan, write, source, review, and update what we publish.

Who we are

Pillo is published by pitcrew Inc. The Pillo app is a medication reminder for Android, used by people managing chronic conditions and complex schedules. Our blog is a separate editorial product. Article content does not promote app features inside medical guidance — app references appear only where directly relevant to adherence (e.g., persistent reminders for missed-dose recovery).

What we publish

Our content covers three domains:

• Specific medications. Missed-dose guidance, accidental double-dose response, best time to take, and timing rules for individual prescription drugs and supplements.
• Medication management. Dosing intervals, schedule design, food and drink interactions, traveling with medications, and adherence routines.
• Patient experience. Starting a new medication, discharge transitions, withdrawal timelines, and side effect navigation.

We do not publish content that recommends specific dosages, dosage changes, or substitutions. Drug-class language ("blood pressure medications," "SSRIs") is used in any context that could be read as medical advice.

How we plan content

Topics start from search demand data and from gaps we observe in existing patient-facing resources. Before drafting, we evaluate:

• Whether the question has a confident, sourceable answer
• Whether existing answers from FDA, NIH, NHS, Mayo Clinic, or peer-reviewed sources are accessible to general readers
• Whether the topic falls within or outside our scope (we exclude topics that require individualized clinical judgment)

How we write and source

Each article goes through a structured pipeline:

1. Research. Authoritative sources are gathered first: FDA prescribing information (DailyMed), NIH and NLM databases, peer-reviewed journals indexed in PubMed, and patient-facing references from Mayo Clinic, NHS, and Cleveland Clinic. We avoid sourcing from forums, AI-generated summaries, and unverified content farms.
2. Drafting. Articles are written for an 8th-grade reading level, pair every claim with a source where required, and lead with the practical answer in the first 50 words.
3. Source verification. Before review, every cited statistic, mechanism claim, and specific number is traced back to its primary source. Articles fail this stage if any claim cannot be verified.
4. Medical review. See Medical Review Policy.
5. Final pass. Plain-language editing for clarity, tone consistency, and accurate representation of risk.

Standards we apply

• Always include the disclaimer. Every article that discusses medications, timing, or symptoms includes a clear statement directing readers to consult their doctor or pharmacist for advice specific to their medications.
• Use drug-class language for guidance. Specific drug names appear in titles and headers for search relevance, but recommendations stay general (e.g., "blood pressure medications" rather than "lisinopril 20 mg twice daily").
• Cite specific numbers. When we state a half-life, a percentage, or a study finding, the source is linked inline.
• Disclose limits. When the right answer is "call your pharmacist" or "this depends on your individual situation," we say so directly rather than over-generalize.

Updates and corrections

We review and update articles when:

• A cited source is updated, retracted, or replaced
• FDA labeling, NIH guidance, or relevant clinical guidelines change
• A reader, clinician, or our review team identifies a factual issue
• Internal review on a 12-month cadence flags content as out of date

Every article shows its last reviewed date. Material corrections are noted at the bottom of the article. Minor edits (typos, link updates, formatting) are not annotated.

Conflict of interest

Pillo is the publisher of this blog and the developer of the Pillo Android app. App references in articles are limited to adherence-relevant contexts and are clearly labeled. We do not accept payment from pharmaceutical companies, supplement brands, or drug-comparison aggregators for editorial coverage.

Comparison articles that mention competitor apps disclose that we publish them and apply the same evaluation criteria across all apps reviewed.

What our content is not

The information we publish is general health education, not medical advice. It does not replace conversation with your prescribing clinician, your pharmacist, or any other licensed healthcare provider who knows your full medication list and medical history.

If you are experiencing a medical emergency, contact emergency services or your local poison control center immediately.

Contact

Editorial concerns, source corrections, or factual disputes:
support@pillo.care

We acknowledge correction requests within 5 business days and respond with our review outcome within 14 days.